EE05395B1 - Epinastiini sisaldavad lahused - Google Patents

Epinastiini sisaldavad lahused

Info

Publication number
EE05395B1
EE05395B1 EEP200200246A EEP200200246A EE05395B1 EE 05395 B1 EE05395 B1 EE 05395B1 EE P200200246 A EEP200200246 A EE P200200246A EE P200200246 A EEP200200246 A EE P200200246A EE 05395 B1 EE05395 B1 EE 05395B1
Authority
EE
Estonia
Prior art keywords
solutions containing
containing epinastine
epinastine
solutions
Prior art date
Application number
EEP200200246A
Other languages
English (en)
Estonian (et)
Inventor
Trach Volker
Duschler Gerold
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05395(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of EE200200246A publication Critical patent/EE200200246A/xx
Publication of EE05395B1 publication Critical patent/EE05395B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
EEP200200246A 1999-11-12 2000-10-14 Epinastiini sisaldavad lahused EE05395B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (2)

Publication Number Publication Date
EE200200246A EE200200246A (et) 2003-06-16
EE05395B1 true EE05395B1 (et) 2011-04-15

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200246A EE05395B1 (et) 1999-11-12 2000-10-14 Epinastiini sisaldavad lahused

Country Status (40)

Country Link
US (6) US20030050303A1 (xx)
EP (1) EP1231920B1 (xx)
JP (1) JP2003514021A (xx)
KR (1) KR100758842B1 (xx)
CN (1) CN1292752C (xx)
AR (1) AR026424A1 (xx)
AT (1) ATE353218T1 (xx)
AU (2) AU784017B2 (xx)
BG (1) BG65775B1 (xx)
BR (1) BR0015477A (xx)
CA (1) CA2391076C (xx)
CO (1) CO5251448A1 (xx)
CY (1) CY1106375T1 (xx)
CZ (1) CZ302483B6 (xx)
DE (2) DE19954516A1 (xx)
DK (1) DK1231920T3 (xx)
EA (1) EA006937B1 (xx)
EE (1) EE05395B1 (xx)
ES (1) ES2281359T3 (xx)
HK (1) HK1052303B (xx)
HR (1) HRP20020404B1 (xx)
HU (1) HU229502B1 (xx)
IL (2) IL149501A0 (xx)
ME (1) MEP36708A (xx)
MX (1) MXPA02004556A (xx)
MY (1) MY130441A (xx)
NO (1) NO329417B1 (xx)
NZ (1) NZ519425A (xx)
PE (1) PE20010826A1 (xx)
PL (1) PL198879B1 (xx)
PT (1) PT1231920E (xx)
RS (1) RS50173B (xx)
SA (1) SA01210658B1 (xx)
SI (1) SI1231920T1 (xx)
SK (1) SK287343B6 (xx)
TR (1) TR200201270T2 (xx)
TW (1) TWI225401B (xx)
UA (1) UA74563C2 (xx)
WO (1) WO2001035962A1 (xx)
ZA (1) ZA200203683B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
DK2934510T3 (da) * 2012-12-19 2021-01-25 Novartis Ag Lfa-1-inhibitorformuleringer
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
JP6487609B1 (ja) * 2017-05-01 2019-03-20 参天製薬株式会社 点眼剤
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US228359A (en) * 1880-06-01 jones
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US215396A (en) * 1879-05-13 Improvement in loom-temples
US181478A (en) * 1876-08-22 Improvement in water-wheels
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US8632A (en) * 1852-01-06 George hess
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
CN1086575C (zh) * 1995-06-27 2002-06-26 贝林格尔·英格海姆公司 用于制备无推进气体的雾剂的新颖稳定药物组合物
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
JP3124041B2 (ja) * 1996-08-30 2001-01-15 京都薬品工業株式会社 アレルギー性皮膚炎治療剤
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1242090A4 (en) * 1999-11-18 2004-02-11 Alcon Inc USE OF AN H1 ANTAGONIST AND A SAFE STEROID IN THE TREATMENT OF EYE CONDITIONS
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
WO2002098112A2 (en) * 2001-05-29 2002-12-05 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
KR100758842B1 (ko) 2007-09-19
CA2391076A1 (en) 2001-05-25
MXPA02004556A (es) 2004-09-10
AU1138101A (en) 2001-05-30
US20070185082A1 (en) 2007-08-09
HUP0203773A3 (en) 2005-01-28
NO329417B1 (no) 2010-10-18
BR0015477A (pt) 2002-06-25
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
PL364028A1 (en) 2004-11-29
US20030050303A1 (en) 2003-03-13
ATE353218T1 (de) 2007-02-15
NZ519425A (en) 2004-04-30
TR200201270T2 (tr) 2002-12-23
UA74563C2 (uk) 2006-01-16
BG106681A (en) 2002-12-29
CN1390129A (zh) 2003-01-08
EP1231920A1 (de) 2002-08-21
PE20010826A1 (es) 2001-08-20
SK8302002A3 (en) 2002-09-10
EA200200492A1 (ru) 2002-10-31
BG65775B1 (bg) 2009-11-30
SA01210658B1 (ar) 2006-11-05
CZ302483B6 (cs) 2011-06-08
HRP20020404B1 (en) 2007-08-31
DK1231920T3 (da) 2007-04-10
IL149501A0 (en) 2002-11-10
CA2391076C (en) 2008-06-17
CO5251448A1 (es) 2003-02-28
AU2006201541A1 (en) 2006-05-11
IL149501A (en) 2012-04-30
KR20020050273A (ko) 2002-06-26
EP1231920B1 (de) 2007-02-07
ZA200203683B (en) 2003-09-03
NO20022201L (no) 2002-05-08
MY130441A (en) 2007-06-29
US20050288274A1 (en) 2005-12-29
US20080009476A1 (en) 2008-01-10
ES2281359T3 (es) 2007-10-01
CN1292752C (zh) 2007-01-03
YU33602A (sh) 2005-03-15
HU229502B1 (en) 2014-01-28
RS50173B (sr) 2009-05-06
DE50014041D1 (de) 2007-03-22
JP2003514021A (ja) 2003-04-15
EE200200246A (et) 2003-06-16
EA006937B1 (ru) 2006-06-30
AU784017B2 (en) 2006-01-12
SI1231920T1 (sl) 2007-06-30
PT1231920E (pt) 2007-03-30
SK287343B6 (sk) 2010-07-07
CZ20021956A3 (cs) 2002-08-14
MEP36708A (en) 2011-02-10
AR026424A1 (es) 2003-02-12
HK1052303A1 (en) 2003-09-11
US20070197503A1 (en) 2007-08-23
DE19954516A1 (de) 2001-05-17
US7429602B2 (en) 2008-09-30
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
HK1052303B (zh) 2007-04-13
WO2001035962A1 (de) 2001-05-25
CY1106375T1 (el) 2011-10-12
PL198879B1 (pl) 2008-07-31
US20090239842A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
EE200200246A (et) Epinastiini sisaldavad lahused
NO2008005I1 (no) Trabectedin
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
DE60011764D1 (de) Werkstoffsprüfung
ATE278002T1 (de) Bleichmittel
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
FI4231U1 (fi) Kotelo
ATE319461T1 (de) Simethicon enthaltendes abführmittel
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE60038153D1 (de) Fahzeugaufhängungen
ID26898A (id) Serat hidrofilik
DE60040745D1 (de) Viertorhybrid
ITMO990105A0 (it) Occhiali
DE60033215D1 (de) Farbband
DE60031136D1 (de) Prozessorarchitectur
DE10082008D2 (de) Ausbeulgerät
ATE269311T1 (de) Benzoylpyridazine
DE60020365D1 (de) Säurekatalysierte umsetzungen
ATE440824T1 (de) Nitro-sulfobenzamide
DE60038096D1 (de) Obreflächenwellenanordnung
ATA107599A (de) Heizwasserbereiter
PT102341A (pt) -
DE60006389D1 (de) Gasfeder
ATA732000A (de) Kachelofen